Latham & Watkins Advises Cryoport in its Public Stock Offering

Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, has announced the closing of an underwritten public offering of 4,356,059 shares of its common stock, at a public offering price of US$66 per share, which includes 568,181 shares issued following the full exercise by the underwriters of their option to purchase additional shares at the public offering price, before deducting underwriting discounts and commissions.

Latham & Watkins LLP represents Cryoport in the offering with Orange County-based deal team led by partners Daniel Rees and Drew Capurro, with associates Traci Biedermann and Tiana Baghdikian. Advice was also provided on tax matters by New York partner Elena Romanova, with associate Lea Li.